What is choline and what does it do in the brain?

Choline is a water-soluble nutrient involved in acetylcholine synthesis (critical for memory and mood regulation), cell membrane structure, and methylation reactions. The brain actively imports choline across the blood-brain barrier. Dietary sources include egg yolk, chicken liver, edamame, kidney beans, and salmon.

Should I take a choline supplement for anxiety?

The current evidence is correlational, not causal — an Australian RCT is underway to test whether choline supplementation moves anxiety outcomes. Choline-rich foods are safe and well-supported for overall brain health. For anxiety management, any dietary strategy is best discussed in the context of your full clinical picture with a GP.

Brain scans find an 8% choline drop across anxiety disorders

What just happened

A meta-analysis published in Molecular Psychiatry — a Nature-family journal — has identified the first transdiagnostic chemical brain marker linked to anxiety disorders. Researchers pooled 25 brain imaging studies using 1H-magnetic resonance spectroscopy (1H-MRS), a technique that uses the same MRI scanner as structural imaging but reads chemical concentrations rather than anatomy, and found that people with anxiety disorders showed approximately 8% lower levels of choline-containing compounds in cortical brain tissue compared with controls. The strongest reduction was in the prefrontal cortex — the region most directly involved in emotional regulation, cognitive reappraisal, and the capacity to modulate a fear response once it’s running.

The finding cuts across subtypes. Whether a participant carried a diagnosis of generalised anxiety disorder, social anxiety, panic disorder, or post-traumatic stress, the pattern held. The term “transdiagnostic” matters here: this is not a marker specific to one type of anxiety; it appears to be a shared neurochemical feature of the anxiety-disorder family.

A larger Australian randomised controlled trial involving 420 participants began in May 2026 and will test whether choline interventions move anxiety outcomes. Results are expected by end of 2026.

Note: This research is international in origin — the meta-analysis draws from global imaging studies and was led by US researchers. Australian primary-tier guidelines (RACGP, NHMRC) have not yet incorporated choline status into anxiety disorder management frameworks. The AU RCT currently underway may inform future guideline development.

For the reader who has been told her anxiety is “just stress” and has found standard pathways inadequate: your brain chemistry has been part of the story that wasn’t being told. Correlation is not causation. But a consistent, directional, cross-diagnostic signal in 25 studies is not nothing.

The both-and

The research is genuinely novel. The clinical application is not yet established. Both are true.

Let me be specific about what this paper did and did not show. It did not demonstrate global choline deficiency — low choline in the liver, blood, or body generally. It showed reduced choline-containing compounds specifically in cortical brain tissue, measured by spectroscopy during MRI. That distinction matters: blood choline levels and brain choline levels are not reliably correlated. The brain actively imports choline across the blood-brain barrier, and that transport is separately regulated from dietary or serum levels.

The UC Davis team involved in earlier complementary work were direct about the limits: the data establish a correlation, and cannot yet answer whether low choline causes anxiety, whether sustained anxiety depletes brain choline over time, or whether a third variable — chronic inflammation, mitochondrial dysfunction, methylation impairment — explains both. The meta-analysis is hypothesis-generating. It is not practice-changing in itself.

The Australian RCT is what changes the calculus. A randomised controlled trial of 420 participants is a reasonable size to detect a meaningful effect if one exists. The trial’s design and results will determine whether dietary or supplemental choline belongs in primary-tier anxiety management guidance, or whether the correlation reflects something else entirely. That answer arrives in roughly six months.

What is reasonable now: choline-containing foods are not fringe. Egg yolk is the most concentrated dietary source — approximately 150 mg of choline per egg, against an adequate daily intake of 425 mg for adult women. Chicken liver, edamame, kidney beans, and salmon follow. These are not interventions with a safety signal relevant to this discussion. They are foods. If the choline-anxiety association proves to be partly causal, optimising dietary choline is a low-cost, low-risk addition to a terrain-management approach that pays off in other directions anyway: choline is a methyl donor, an acetylcholine precursor, and a membrane phospholipid component.

Hold both: the mechanistic signal is real, novel, and worth watching. The intervention is not yet proven.

2 cents

This is an international finding. The primary research was led by US institutions and the meta-analysis draws from global studies. AU primary-tier bodies (RACGP, NHMRC) have not yet updated anxiety management frameworks to include choline status. That is not unusual — the meta-analysis is recent. The guideline pipeline typically lags the research by 18 to 36 months.

The AU RCT is the watch-this moment. When results are published in late 2026, the question of whether choline belongs in a clinical anxiety management conversation will have an answer from Australian data. Until then, the evidence sits at “plausible, correlational, and worth being curious about.”

The rest of anxiety management — sleep architecture, breath mechanics and vagal tone, methylation support, gut-brain axis, the cortisol load from structural life stress — does not step aside because one nutrient marker looks interesting. Choline is potentially one more handle on a multi-lever system.

If dietary choline is part of what you are already tracking, you are ahead of where the guidelines will probably end up. If it has not been on your radar: eggs for breakfast is a reasonable place to start.

This is general information. Anxiety presentations vary widely in cause and severity. A single nutrient marker does not define or resolve the picture — that discussion belongs with a GP who can see the whole terrain.

Verdict

Verdict: yes — worth knowing about.

A meta-analysis of 25 imaging studies found 8% lower brain choline across anxiety disorder subtypes — the first transdiagnostic chemical marker of its kind. Correlation not causation, confirmed. An Australian RCT of 420 participants reports end of 2026. For now: dietary choline from whole food sources is a low-risk, nutritionally sound addition to any anxiety-terrain approach. The science is in motion; the egg is not waiting for the RCT.